Recent Finacing
Recent Raise
Empress Therapeutics, based in Cambridge, MA, develops small-molecule drug candidates using its Chemilogics platform that decodes genetic programming of cellular metabolite production to generate therapeutic leads.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Empress Therapeutics.
